2.3300
-0.0500
(-2.10%)
As of 9:39:41 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
8,278.0000
-1,318.0000
-25,000.0000
-10,285.0000
-26,106.0000
Investing Cash Flow
19,199.0000
-16,711.0000
-5,035.0000
18,921.0000
-19,952.0000
Financing Cash Flow
-20,420.0000
24,666.0000
8,238.0000
12,078.0000
46,467.0000
End Cash Position
27,465.0000
23,634.0000
17,111.0000
38,985.0000
18,265.0000
Interest Paid Supplemental Data
--
--
--
3,410.0000
4,344.0000
Capital Expenditure
-1,107.0000
-1,149.0000
-628.0000
-1,459.0000
-655.0000
Issuance of Capital Stock
--
23,954.0000
8,236.0000
46,200.0000
46,210.0000
Repayment of Debt
--
--
--
-34,122.0000
-215.0000
Free Cash Flow
7,171.0000
-2,467.0000
-25,628.0000
-11,744.0000
-26,761.0000
12/31/2020 - 5/15/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLRX BioLineRx Ltd.
3.3600
-5.88%
ARDX Ardelyx, Inc.
5.31
-0.93%
CANF Can-Fite BioPharma Ltd.
1.5500
+1.31%
ALDX Aldeyra Therapeutics, Inc.
5.52
+2.22%
VSTM Verastem, Inc.
6.30
+1.29%
EYEN Eyenovia, Inc.
0.0356
+2.01%
RVPH Reviva Pharmaceuticals Holdings, Inc.
1.8203
-1.07%
CGEN Compugen Ltd.
2.3600
+0.43%
PTN Palatin Technologies, Inc.
0.9150
+1.69%
FBIO Fortress Biotech, Inc.
1.8000
+1.12%